Covered recipient · General Payments record
RYAN KARY MUTH
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$1,768.09
- Reported across 98 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $547.87 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $229.60 | 22 |
| GlaxoSmithKline, LLC. | $92.76 | 4 |
| ABIOMED | $51.83 | 2 |
| Novo Nordisk AS | $46.88 | 2 |
| Merck Sharp & Dohme Corporation | $30.23 | 1 |
| Lilly USA, LLC | $24.80 | 1 |
| Actelion Pharmaceuticals US, Inc. | $23.84 | 1 |
| PFIZER INC. | $20.72 | 1 |
| Amgen Inc. | $14.00 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.53 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107713981 | CMS |
| ABBVIE INC. | $1.38 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107713983 | CMS |
| ABBVIE INC. | $15.88 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107713985 | CMS |
| ABBVIE INC. | $2.88 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107713987 | CMS |
| ABBVIE INC. | $25.63 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107713989 | CMS |
| ABBVIE INC. | $5.91 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107713991 | CMS |
| ABBVIE INC. | $11.25 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107713993 | CMS |
| ABBVIE INC. | $10.96 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107713995 | CMS |
| ABBVIE INC. | $30.68 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107713997 | CMS |
| ABBVIE INC. | $32.75 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107713999 | CMS |
| ABBVIE INC. | $1.62 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107714001 | CMS |
| ABBVIE INC. | $11.37 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107714003 | CMS |
| ABBVIE INC. | $26.98 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107714005 | CMS |
| ABBVIE INC. | $8.23 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107714007 | CMS |
| ABBVIE INC. | $2.18 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107714009 | CMS |
| ABBVIE INC. | $1.87 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107714011 | CMS |
| ABBVIE INC. | $11.11 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107714013 | CMS |
| ABBVIE INC. | $0.89 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107714015 | CMS |
| ABBVIE INC. | $4.03 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107714017 | CMS |
| ABBVIE INC. | $5.52 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107714019 | CMS |
| ABBVIE INC. | $1.86 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107714021 | CMS |
| ABBVIE INC. | $4.09 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107714023 | CMS |
| ABIOMED | $27.64 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142288603 | CMS |
| ABIOMED | $24.19 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142288647 | CMS |
| Actelion Pharmaceuticals US, Inc. | $23.84 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078867453 | CMS |
| Amgen Inc. | $14.00 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117637089 | CMS |
| GlaxoSmithKline, LLC. | $15.84 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115986331 | CMS |
| GlaxoSmithKline, LLC. | $25.00 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116333485 | CMS |
| GlaxoSmithKline, LLC. | $23.00 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116662719 | CMS |
| GlaxoSmithKline, LLC. | $28.92 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116703252 | CMS |
| Lilly USA, LLC | $24.80 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135939812 | CMS |
| Merck Sharp & Dohme LLC | $30.23 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141585892 | CMS |
| Novo Nordisk Inc | $26.78 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100293756 | CMS |
| Novo Nordisk Inc | $20.10 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100373266 | CMS |
| PFIZER INC. | $20.72 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132032801 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.21 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137798071 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.